about
Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDsPharmacoepidemiology studies: what levels of evidence and how can they be reached?Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting systemAddition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisLiver transplant associated with paracetamol overdose: results from the seven-country SALT studyExploring the potential prognostic effect of various country-specific health service data on all-cause mortality using data from a large prospective study in schizophrenia.Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shockTraditional Uighur Medicine Karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitroA population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies.Scoring of medical publications with SIGAPS software: Application to orthopedics.Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility study.The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge.Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies.News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery.A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU.Does paracetamol still have a future in osteoarthritis?Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.Effect of Ocimum basilicum L. on cyclo-oxygenase isoforms and prostaglandins involved in thrombosis.Observation of the long-term effects of lifestyle intervention during balneotherapy in metabolic syndrome.Persistence to 5-year hormonal breast cancer therapy: a French national population-based study.Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study.Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting.A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort.Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database.Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies.Usage patterns of paracetamol in France.Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo.Acute and sub-chronic (28days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals.
P50
Q26800279-F73C2075-6C7B-48CF-9235-FFFDA0391EBAQ27021654-C8277D2E-745B-44B4-973F-B954AF11152FQ28257188-F31C5CAE-C2D0-4467-AE93-8A5E9E8A77CAQ28275281-7150588D-EA72-4B97-80F8-1BE184DA44AFQ28607494-366BBF59-DC51-4E19-AEC8-005065EE5430Q30579740-435CC0ED-EB28-4BFD-BEB8-9E1EE37E9427Q34597640-2163F7DA-A0BE-4224-8763-1A710A67364BQ35577178-C0EE6106-35BD-4C17-AC6A-5BDD2D0AD639Q36618123-36E4349B-55C6-4820-9CF8-B86426327E8EQ37576287-E9D579B6-EA4A-4186-B97B-DE3683BE9AEDQ37731873-C3128D2F-67EF-48BB-95D0-2519C1D5A623Q38164425-1663FCCB-9CFA-410A-928F-0FFADCC4B553Q38201752-C4B271CC-87F4-404F-9E75-967B41882DCEQ38274195-3FEEAD03-47A2-4C9B-BF96-848108FA21ADQ38388586-733BA176-4A71-462F-934F-E37BA8A16DC6Q38682567-DD680603-C307-40B1-9E3F-DFF1986EE7C1Q38749318-C06C7826-3E2F-43BB-ADBE-F9AE10AE3A15Q38764020-E853060C-41C0-4C1B-8337-E7D2FDA74699Q38804897-5C88960F-D969-42E1-A359-5E3871CC4495Q38833125-5C5813C4-6052-4B44-98EB-A86FB83D16A4Q38864210-056CC499-17A8-480E-93A4-DE72B08B85ABQ38874756-AA05AB58-3112-454F-892C-83C5164C5127Q38892476-13A8CBE2-F1C5-4D91-BCE7-D8D3699B8F08Q38998154-1EA68A1C-C6CD-4868-AED5-F736B416BD43Q39035465-CE5B5049-310F-4D29-822D-5B68CDCD38E7Q39378256-77B36051-46FE-4C2B-95C7-408C8A9C4BE3Q39419032-58964D68-D8D9-4DD5-AD22-FD4884170B95Q39644204-50D81ABF-8DEE-4367-9F10-BF298B4DF9C4Q40018415-53A279B8-9B41-4F10-9053-2BAC88167FB0Q40160191-683EA71A-697D-4DBC-B911-60435CF82D0AQ40272818-67CDC4B9-04ED-4EBA-A378-03E711B9A303Q40511222-A5FE27BE-53CB-46FC-8994-339DADD13C53Q40613410-DCDB01FE-4C05-4336-9C62-E5C4D89A70E5Q40616446-7E1C4AE6-9713-4B8F-8B40-DF6B22DA90E1Q41483593-09FD01FC-C4F4-4C19-BF71-DB2525A8D534Q42382870-87549B5A-81D5-4D91-A335-35F0ECAACDEDQ43858864-62D20CF1-C547-4CDD-B6A4-CDCDEB0411D1Q43897779-45FF0665-783B-4E4F-99B3-D471C9D6F473Q44037738-16339E37-C4C5-4578-859E-3A38C78B58B5Q44153892-A65B0538-417E-4447-AA15-9E95EED604BF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicholas Moore
@ast
Nicholas Moore
@en
Nicholas Moore
@es
Nicholas Moore
@nl
type
label
Nicholas Moore
@ast
Nicholas Moore
@en
Nicholas Moore
@es
Nicholas Moore
@nl
prefLabel
Nicholas Moore
@ast
Nicholas Moore
@en
Nicholas Moore
@es
Nicholas Moore
@nl
P106
P1153
7202879769
P21
P31
P496
0000-0003-1212-2817